CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Biocorrx Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Biocorrx Inc
2390 EAST ORANGEWOOD AVENUE, SUITE 500
Phone: (714) 462-4880p:714 462-4880 ANAHEIM, CA  92806  United States Ticker: BICXBICX

Business Summary
BioCorRx Inc. is a holding company. The Company through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders. Its BioCorRx Recovery Program is a non-addictive, medication-assisted treatment (MAT) program for substance abuse that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application. The Company is also engaged in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. The Company is also engaged in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. Its products include BICX101 and BICX102. BICX101 is a sustained release, injectable naltrexone for the treatment of opioid abuse and alcoholism. The Company's subsidiary is BioCorRx Pharmaceuticals.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202112/31/2020YesYes--Yes

Industries
SIC Code Description
8361 Residential care

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Director Brady J.Granier 48 11/9/2020 9/13/2013
Chief Executive Officer, Chief Financial Officer, Treasurer, Director LourdesFelix 53 11/9/2020 10/1/2012
Executive Vice President Thomas P.Welch 49 2/26/2020 6/17/2016
4 additional Officers and Directors records available in full report.

Business Names
Business Name
BICX
BICXD
BioCorRx Pharmaceuticals
6 additional Business Names available in full report.

General Information
Number of Employees: 5 (As of 12/31/2011)
Outstanding Shares: 6,690,706 (As of 11/12/2021)
Shareholders: 142
Stock Exchange: OTC
Federal Tax Id: 261972677


Copyright © 2022 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, January 28, 2022